NDRA ENDRA Life Sciences Inc.

Nasdaq endrainc.com


$ 7.85 $ 0.69 (9.7 %)    

Wednesday, 15-Oct-2025 10:44:48 EDT
QQQ $ 606.27 $ 2.45 (0.41 %)
DIA $ 465.96 $ 1.32 (0.28 %)
SPY $ 669.17 $ 2.39 (0.36 %)
TLT $ 91.08 $ 0.12 (0.13 %)
GLD $ 386.32 $ 0.36 (0.09 %)
$ 6.99
$ 7.49
$ 7.75 x 1
$ 7.85 x 105
$ 7.42 - $ 7.80
$ 2.90 - $ 22.68
187,492
na
5.26M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-19-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-25-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-26-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-11-2019 12-31-2018 10-K
28 11-05-2018 09-30-2018 10-Q
29 08-13-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-20-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-07-2017 06-30-2017 10-Q
34 06-21-2017 03-31-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 endra-life-sciences-gains-momentum-with-crypto-focused-treasury-plan

ENDRA Life Sciences Inc. (NASDAQ: NDRA) announced $4.9M in funding to launch a digital asset treasury strategy.

 ascendiant-capital-maintains-buy-on-endra-life-sciences-lowers-price-target-to-38

Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and lowers the price target fro...

 endra-life-sciences-q2-eps-171-beats-227-estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.71) per share which beat the analyst consensus estimate of $...

 endra-life-sciences-launches-bitcoin-treasury-strategy-forms-advisory-board-with-james-altucher-james-manning-and-rayne-steinberg

The Board of Directors (the "Board") of ENDRA Life Sciences Inc. (the "Company") has authorized the Company to ...

 endra-life-sciences-expects-q2-2025-loss-of-13m-no-revenue-and-26m-in-total-assets

Recent Financial ResultsBelow is a summary of certain preliminary estimates regarding our financial results for the quarter end...

 endra-life-sciences-files-for-offering-of-157m-shares-of-common-stock

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION